The asymmetric unit of the title crystal structure is shown in the gure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.
Source of material
The title compound was synthesized according to a reported procedure [1] . A mixture of 3,5-cyclohexanedione (10 mmol), 3,5-dichlorobenzaldehyde (10 mmol), malononitrile (10 mmol) and 4-(dimethylamino)pyridine (DMAP) (1 mmol) in ethanol (100 mL) was re uxed for 2-3 h and then cooled to room temperature. After ltering the precipitates, *Corresponding author: Jing He, Department of Chemistry and Chemical Engineering, Shaanxi Xueqian Normal University, Xi'an, China, e-mail: Jing_he3157@126.com . 
they were sequentially washed with ice-cooled water and ethanol and then dried under a vacuum.
Experimental details
H atoms were placed in calculated positions and were included in the re nement in the riding model approximation, with U iso (H) set to 1.2Ueq(C).
Discussion
Dihydropyrans represent one of the most active classes of compounds possessing a wide spectrum of biological activities [2] [3] [4] , including anticoagulant, insecticidal, anthelminthic, hypnotic, antifungal, phytoalexin, and HIV protease inhibition. The interesting biological activity of these dihydropyrans made these compounds attractive targets in organic synthesis [5] .
In the crystal structure of the title compound, the chromene core shows a typical folding [6, 7] . Expectedly, the phenyl ring makes a torsion angle to the pyran ring. All bond lengths and angles are in the typical ranges.
